Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Gilead Sciences is 'Strong Hold'. Macroaxis provides Gilead Sciences buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Gilead Sciences positions. The advice algorithm takes into account all of Gilead Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Gilead Sciences buy-and-hold prospective. Please also check Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
Gilead Sciences Current RecommendationFor the selected time horizon Gilead Sciences has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0Macroaxis provides unbiased buy or sell recommendations on Gilead Sciences that should be used to complement current analysts and expert consensus on Gilead Sciences. Our buy, hold, or sell suggestion engine determines the entity potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Gilead Sciences is not overpriced, please check out all Gilead Sciences fundamentals including its Gross Profit, Debt to Equity and the relationship between Price to Book and Cash and Equivalents . Given that Gilead Sciences has Price to Earning of 27.03 times, we strongly advise you confirm Gilead Sciences market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.
Gilead Sciences Thematic Classifications
Returns Distribution Density
Gilead Sciences Greeks
Gilead Sciences Volatility Alert
|Better Than Average||Worse Than Average||Compare Gilead Sciences to competition|